Amanda Jude, DO
Geriatric Medicine · Cincinnati, OHNPI 1174028443
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 253 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 12.8% — the pattern of someone who eats at a lot of different presentations.
Across 253 payments — averaging $17.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$571
- Novo Nordisk$553
- Corcept Therapeutics$330
- AbbVie$274
- Amgen$228
- Exact Sciences$224
- plus $2K from 33 others
What the payments were for
- Food & beverage$4,430100%
- Education$200%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 42 | $571 |
| Novo Nordisk | 30 | $553 |
| Corcept Therapeutics | 16 | $330 |
| AbbVie | 16 | $274 |
| Amgen | 13 | $228 |
| Exact Sciences | 11 | $224 |
| Bayer | 12 | $212 |
| Pfizer | 15 | $207 |
| GSK | 12 | $202 |
| Sanofi-aventis U.S. LLC | 10 | $179 |
| AstraZeneca | 3 | $149 |
| Teva Pharmaceuticals USA, Inc. | 7 | $142 |
| Novartis | 7 | $131 |
| Otsuka America Pharmaceutical, Inc. | 6 | $111 |
| Xeris Pharmaceuticals, Inc. | 5 | $85 |
| Merck | 5 | $80 |
| Mannkind Corporation | 4 | $66 |
| Paratek Pharmaceuticals, Inc. | 3 | $65 |
| Esperion Therapeutics, Inc. | 4 | $61 |
| Medtronic | 2 | $53 |
| Astellas Pharma US Inc | 3 | $51 |
| Boehringer Ingelheim | 3 | $50 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $45 |
| Sanofi Pasteur Inc. | 2 | $42 |
| Insulet Corporation | 2 | $38 |
| Sumitomo Pharma America, Inc. | 2 | $33 |
| Avanir Pharmaceuticals, Inc. | 1 | $32 |
| Cranial Technologies, Inc | 2 | $31 |
| Seqirus USA Inc | 2 | $28 |
| Teleflex LLC | 1 | $24 |
| Sequel Med Tech, LLC | 1 | $24 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $22 |
| Viiv Healthcare Company | 1 | $21 |
| Gilead | 1 | $19 |
| BETA Bionics, Inc. | 1 | $17 |
| Amphastar Pharmaceuticals, Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Cequr Corporation | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,451 in reported general payments places this provider in the 85th percentile of 146 geriatric medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 81 | $93,316 |
| OzempicSemaglutide | 59 | $71,383 |
| EliquisApixaban | 55 | $64,443 |
| TrulicityDulaglutide | 40 | $51,171 |
| FarxigaDapagliflozin Propanediol | 47 | $46,864 |
| XareltoRivaroxaban | 48 | $32,563 |
| MounjaroTirzepatide | 20 | $27,503 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $25,121 |
| JanuviaSitagliptin Phosphate | 27 | $19,002 |
| MyrbetriqMirabegron | 23 | $18,660 |
| EntrestoSacubitril/Valsartan | 11 | $16,667 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $8,931 |
| Repatha SureclickEvolocumab | 13 | $6,967 |
| Atorvastatin Calcium | 820 | $6,128 |
| PaxlovidNirmatrelvir/Ritonavir | 18 | $5,593 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $50 | $93,31681 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $571 | $78,67460 claims |
| Novo NordiskOzempic | $553 | $71,38359 claims |
| PfizerEliquis, Paxlovid | $207 | $70,03673 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $149 | $55,79460 claims |
| Johnson & JohnsonXarelto | $15 | $32,56348 claims |
| GSKTrelegy Ellipta | $202 | $25,12123 claims |
| MerckJanuvia | $80 | $19,00227 claims |
| Astellas Pharma US IncMyrbetriq | $51 | $18,66023 claims |
| NovartisEntresto | $131 | $16,66711 claims |
| AbbVieSynthroid | $274 | $1,58249 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 146 geriatric medicine providers in Ohio.
Other geriatric medicine in Cincinnati
- James FidelholtzCincinnati$15K
- Milla KarevCincinnati$5K
- Emmanuel RiveraCincinnati$2K
- Robert KeyesCincinnati$965
- Syed MoqeethCincinnati$676
- Shachi SinghCincinnati$426
- Jeffrey LeksonCincinnati$373
- Amanda ArnoldCincinnati$310
- Meenakshi PatelCenterville$644K
- Daniel CannoneWadsworth$423K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.